Immunocore Holdings (IMCR) Stock Statistics & Valuation Metrics

Immunocore Holdings has a market cap or net worth of $1.56B. The enterprise value is $1.14B.

Immunocore Holdings has 50,695,080 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immunocore Holdings’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -4.10%.

The current PE Ratio of Immunocore Holdings is ―. Immunocore Holdings’s PEG ratio is 1.38.

In the last 12 months, Immunocore Holdings had revenue of 297.57M and earned -26.42M in profits. Earnings per share was -0.53.

In the last 12 months, operating cash flow was -10.71M and capital expenditures -4.34M, giving a free cash flow of -15.05M billion.

Immunocore Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Immunocore Holdings upcoming earnings date is May 13, 2026, Before Open (Confirmed).

Immunocore Holdings as a current ratio of 4.04, with Debt / Equity ratio of 11.43%

In the past 12 months, Immunocore Holdings has paid 12.21M in taxes.

Immunocore Holdings EV to EBITDA ratio is 3.42K, with an EV/FCF ratio of -118.19.

Immunocore Holdings has $864.15M in cash and marketable securities with $43.56M in debt, giving a net cash position of $820.59M billion.

Gross margin is 98.66%, with operating margin of -11.34%, and net profit margin of -8.88%.

The average price target for Immunocore Holdings is $65.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy